News

2019

company

year

domain

Sarah Hlavinka Elected to Quanterix Board of Directors

Quanterix 07.26.2019

Evelo Biosciences Secures $45 Million Debt Financing from K2 HealthVentures

Evelo Biosciences 07.25.2019

Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy

07.25.2019

Kintai Therapeutics Announces the Appointment of Mary Szela, Industry Veteran with Over 30 Years of Executive Experience, to its Board of Directors

07.23.2019

Kaleido Biosciences Appoints Jerald Korn as General Counsel and Corporate Secretary

07.22.2019

Kaleido Biosciences Announces Appointment of Theo Melas-Kyriazi to its Board of Directors

07.15.2019

Miraca and Seventh Sense Biosystems, Inc. Announce Strategic Investment and Distribution Agreement

YourBio Health 07.01.2019

Kaleido Biosciences to Highlight Chemistry-Driven Approach at Microbiome Movement – Drug Development Summit

06.28.2019

Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota Transplantationse

Seres Therapeutics 06.19.2019

FDA Grants Fast Track Designation for Torque’s First Deep-Primed T Cell Cancer Immunotherapy Program, TRQ-1501

06.18.2019

Loading